Abstract

The Clinical Laboratory and Biomarkers Core will facilitate and coordinate access to laboratory expertise. The overall goal of this core is to assure that all JHU HIV investigators, particularly junior investigators, will have the greatest possible access to expertise on the appropriate use of and the laboratory assays required for addressing their research questions. This Core will also establish and maintain a biomarker specimen repository for storing and accessing biological specimens. The Core will interact with the Administrative, Developmental, Clinical, Prevention and Biostats, Epidemiology and Methods cores, as well as with the Scientific Working Groups, to assure access to cutting edge and quality-assured laboratory methodologies to junior and new investigators conducting research on HIV in Baltimore and globally.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI094189-03
Application #
8653930
Study Section
Special Emphasis Panel (ZAI1-RRS-A)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
3
Fiscal Year
2014
Total Cost
$272,625
Indirect Cost
$104,338

  Institution

Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218

  Publications

Page, Kathleen R; Grieb, Suzanne Dolwick; Nieves-Lugo, Karen et al. (2018) Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings. Lancet HIV 5:e597-e604
Sengupta, Srona; Siliciano, Robert F (2018) Targeting the Latent Reservoir for HIV-1. Immunity 48:872-895
Dean, Lorraine T; Moss, Shadiya L; Ransome, Yusuf et al. (2018) ""It still affects our economic situation"": long-term economic burden of breast cancer and lymphedema. Support Care Cancer :
Solomon, S S; Sulkowski, M S; Amrose, P et al. (2018) Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT). J Viral Hepat 25:37-46
Lee, Hana; Wu, Xiaotian K; Genberg, Becky L et al. (2018) Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort. AIDS 32:2217-2225
Doby, Brianna L; Tobian, Aaron A R; Segev, Dorry L et al. (2018) Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma. Curr Opin Organ Transplant 23:271-278
Hoffmann, Christopher J; Milovanovic, Minja; Kinghorn, Anthony et al. (2018) Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa. PLoS One 13:e0201032
Park, Ju Nyeong; Weir, Brian W; Allen, Sean T et al. (2018) Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J 15:34
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Mukandavire, Christinah; Walker, Josephine; Schwartz, Sheree et al. (2018) Estimating the contribution of key populations towards the spread of HIV in Dakar, Senegal. J Int AIDS Soc 21 Suppl 5:e25126

Showing the most recent 10 out of 724 publications